These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6678555)

  • 21. [Use of ednit in the treatment of portal hypertension in patients with chronic hepatitis and liver cirrhosis].
    Maev IV; Kaziulin AN; Andreev NG; Aksel'rod AG; Nikushkina IN
    Ter Arkh; 2001; 73(10):79-83. PubMed ID: 11763526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of active gastroesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis. A randomized controlled trial.
    García-Compeán D; Blanc P; Bories JM; Michel J; Desprez D; Pageaux GP; David XR; Larrey D; Michel H
    Arch Med Res; 1997; 28(2):241-5. PubMed ID: 9204616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-blockers.
    Bursey RF
    Can J Gastroenterol; 1998; 12(8):542-3. PubMed ID: 9926263
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does losartan work after all?
    Blendis LM; Wong F
    Am J Gastroenterol; 2003 Jun; 98(6):1222-4. PubMed ID: 12818261
    [No Abstract]   [Full Text] [Related]  

  • 26. Rapid normalization of portopulmonary hypertension after living donor liver transplantation.
    Sugimachi K; Soejima Y; Morita K; Ueda S; Fukuhara T; Nagata S; Ikegami T; Taketomi A; Maehara Y
    Transplant Proc; 2009 Jun; 41(5):1976-8. PubMed ID: 19545772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug treatment for portal hypertension due to cirrhosis].
    Lebrec D; Benhamou JP
    Gastroenterol Clin Biol; 1982; 6(6-7):542-8. PubMed ID: 6126417
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological treatment of portal hypertension.
    González-Abraldes J; Bosch J; García-Pagán JC
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dose-dependent acute effect and long-term modification by molsidomine of portal and cardiac hemodynamics in patients with liver cirrhosis].
    Hüppe D; Jäger D; Tromm A; Barmeyer J; May B
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():65-8, 76. PubMed ID: 7968910
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental pharmaceutical therapy of sinusoidal portal hypertension].
    Tarantino G; Mascolo G; Vitaglione R; De Rosa G
    Boll Chim Farm; 1984 Jan; 123(1):6S-15S. PubMed ID: 6721936
    [No Abstract]   [Full Text] [Related]  

  • 31. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
    De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
    Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary complications in cirrhosis.
    Sussman NL; Kochar R; Fallon MB
    Curr Opin Organ Transplant; 2011 Jun; 16(3):281-8. PubMed ID: 21543981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Viskaldix for treatment of patients with moderate arterial hypertension. Comparative estimation of hemodynamic changes during treatment with Viskaldix and Stresson].
    Grajek S; Szymczyńska A; Urbański K; Lehman Z; Kozłowska F; Paradowski S; Gracz M
    Kardiol Pol; 1986; 29(7):440-53. PubMed ID: 2879953
    [No Abstract]   [Full Text] [Related]  

  • 34. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A
    Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.
    Hernández-Guerra M; García-Pagán JC; Turnes J; Bellot P; Deulofeu R; Abraldes JG; Bosch J
    Hepatology; 2006 Mar; 43(3):485-91. PubMed ID: 16496307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamics in the isolated cirrhotic liver.
    Zipprich A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nadolol, a long-term acting beta blocking agent, in the treatment of essential arterial hypertension].
    Semplicini A; Pessina AC; Rossi GP; Tagliafierro R; Lusiani L; Castellani V; Bedogni F; Mazzucato A; Ronsisvalle G
    Cardiologia; 1982 Sep; 27(9):853-64. PubMed ID: 6765278
    [No Abstract]   [Full Text] [Related]  

  • 38. [Propranolol and portal hypertension in cirrhotic patients. Manometric and hemodynamic studies].
    Reding P; Urbain D; Frère D; Thys O; Grivegnée A
    Acta Gastroenterol Belg; 1986; 49(3):324-8. PubMed ID: 3825447
    [No Abstract]   [Full Text] [Related]  

  • 39. Redistribution of cardiac output to the kidneys during oral nadolol administration.
    Textor SC; Fouad FM; Bravo EL; Tarazi RC; Vidt DG; Gifford RW
    N Engl J Med; 1982 Sep; 307(10):601-5. PubMed ID: 7110207
    [No Abstract]   [Full Text] [Related]  

  • 40. Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation.
    Kett DH; Acosta RC; Campos MA; Rodriguez MJ; Quartin AA; Schein RM
    Liver Transpl; 2001 Jul; 7(7):645-8. PubMed ID: 11460234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.